Another small trial, the Effect of Semaglutide 2.4 mg Once Weekly on Function and Symptoms in Subjects with Obesity-related Heart Failure with Preserved Ejection Fraction (STEP-HFpEF) trial assesed semaglutide efficay in patients with preserved LVEF (LVEF 45%) and obesity (BMI 30 kg/m 2 )
JoganiVGMohamed ElfadilOEdakkanambeth VarayilJMundiMS
Pharmacy partners
& Cruff, J
J Thromb Haemost 22:14961509
Solely for convenience, trademarks, service marks and trade names referred to in this report and the information incorporated herein, including logos, artwork, and other visual displays, may appear without the or symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks, service marks and trade names